Berger Disease Active Not Recruiting Phase 2 Trials for Atacicept (DB06399)

IndicationStatusPhase
DBCOND0117712 (Berger Disease)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04716231Atacicept in Subjects With IgA NephropathyTreatment